WO2013184036A3 - Agent de protection hépatique - Google Patents

Agent de protection hépatique Download PDF

Info

Publication number
WO2013184036A3
WO2013184036A3 PCT/RU2013/000466 RU2013000466W WO2013184036A3 WO 2013184036 A3 WO2013184036 A3 WO 2013184036A3 RU 2013000466 W RU2013000466 W RU 2013000466W WO 2013184036 A3 WO2013184036 A3 WO 2013184036A3
Authority
WO
WIPO (PCT)
Prior art keywords
hepatoprotective agent
hepatoprotective
agent
caryophyllene
derivatives
Prior art date
Application number
PCT/RU2013/000466
Other languages
English (en)
Russian (ru)
Other versions
WO2013184036A2 (fr
Inventor
Михаил Александрович ГЕТЬМАН
Юрг ГЕРЧ
Original Assignee
Getman Mikhail Alexandrovich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Getman Mikhail Alexandrovich filed Critical Getman Mikhail Alexandrovich
Publication of WO2013184036A2 publication Critical patent/WO2013184036A2/fr
Publication of WO2013184036A3 publication Critical patent/WO2013184036A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne un agent de protection hépatique se composant essentiellement de caryophyllène ou de dérivés de celui-ci ou de sels pharmaceutiquement acceptables.
PCT/RU2013/000466 2012-06-07 2013-06-06 Agent de protection hépatique WO2013184036A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EA201200799A EA024466B1 (ru) 2012-06-07 2012-06-07 Гепатопротекторное средство
EA201200799 2012-06-07

Publications (2)

Publication Number Publication Date
WO2013184036A2 WO2013184036A2 (fr) 2013-12-12
WO2013184036A3 true WO2013184036A3 (fr) 2014-03-27

Family

ID=49712780

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2013/000466 WO2013184036A2 (fr) 2012-06-07 2013-06-06 Agent de protection hépatique

Country Status (2)

Country Link
EA (1) EA024466B1 (fr)
WO (1) WO2013184036A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7466748B1 (ja) 2023-08-18 2024-04-12 日本たばこ産業株式会社 肝機能の維持又は改善用組成物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62132822A (ja) * 1985-12-05 1987-06-16 Eisai Co Ltd 肝炎治療剤
RU2327482C1 (ru) * 2006-12-28 2008-06-27 Дмитрий Николаевич Мясников Композиция и способ лечения постинтоксикационного состояния и алкогольного абстинентного синдрома - похмелья (варианты)
WO2008144880A1 (fr) * 2007-05-31 2008-12-04 F.P.L. Pharma Inc. Compositions servant à prévenir ou à traiter le syndrome d'anorexie-cachexie et leurs procédés d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60323088D1 (de) * 2002-05-10 2008-10-02 Council Scient Ind Res Leberschützende wirkung der 10-o-p-hydroxybenzoylaucubin
US7625587B2 (en) * 2006-11-16 2009-12-01 Jose Angel Olalde Rangel Hepato phyto-nutraceutical synergistic composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62132822A (ja) * 1985-12-05 1987-06-16 Eisai Co Ltd 肝炎治療剤
RU2327482C1 (ru) * 2006-12-28 2008-06-27 Дмитрий Николаевич Мясников Композиция и способ лечения постинтоксикационного состояния и алкогольного абстинентного синдрома - похмелья (варианты)
WO2008144880A1 (fr) * 2007-05-31 2008-12-04 F.P.L. Pharma Inc. Compositions servant à prévenir ou à traiter le syndrome d'anorexie-cachexie et leurs procédés d'utilisation

Also Published As

Publication number Publication date
WO2013184036A2 (fr) 2013-12-12
EA024466B1 (ru) 2016-09-30
EA201200799A1 (ru) 2013-12-30

Similar Documents

Publication Publication Date Title
NO2022031I1 (no) Voxelotor or a tautomer or pharmaceutically acceptable salt thereof
NO2021034I1 (no) pemigatinib or a pharmaceutically acceptable salt thereof
FIC20200022I1 (fi) Yhdistelmä, joka käsittää fosnetupitanttia tai sen farmaseuttisesti hyväksyttävää suolaa ja palonosetronia tai sen farmaseuttisesti hyväksyttävää suolaa
NO2023032I1 (en) Deucravacitinib or a pharmaceutically acceptable salt thereof
NO2022010I1 (no) ripretinib, or a pharmaceutically acceptable salt thereof
NO2021041I1 (no) remimazolam or a pharmaceutically acceptable salt thereof
NL300947I2 (nl) Bictegravir of een farmaceutisch aanvaardbaar zout daarvan, in het bijzonder bictegravirnatrium
FIC20240022I1 (fi) Retsafungiini tai sen farmaseuttisesti hyväksyttävä suola, erityisesti retsafungiiniasetaatti
HK1186978A1 (en) Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
EP3133068A4 (fr) Dérivés d'amides et leurs sels pharmaceutiquement acceptables, leur procédé de préparation et leur utilisation médicale
EP2706855A4 (fr) Solutions aqueuses de 1,2-benzisothiazolin-3-one
IL246133A0 (en) A sulfonamide derivative or their pharmaceutically acceptable acid addition salts
HK1186737A1 (en) Derivatives of azaindazole or diazaindazole type as medicament
EP2746283A4 (fr) Dérivés de pyrimidopyrimidone, compositions pharmaceutiques et leurs utilisations
NZ704266A (en) Inhibitors of alpha-crystallin aggregation for the treatment for cataract
EP3075726A4 (fr) Dérivé d'urée ou sel pharmacologiquement acceptable de celui-ci
PT2739285T (pt) Inibição seletiva da protease malt1 por meio de derivados de fenotiazina
IL228408A0 (en) History as Falosporin and their medicinal preparations
WO2011079193A3 (fr) Préparation de la bendamustine et de ses sels
EP2877469A4 (fr) Dérivés de naphthyridinedione substitués en tant qu'inhibiteurs de l'intégrase du vih
WO2014033526A9 (fr) Compositions pharmaceutiques d'étoricoxib
IL232404A0 (en) n-(4-quinolinylmethyl)-sulfonamide derivatives and their use as anthelmintics
EP2609933A4 (fr) Composition aqueuse pour administration ophtalmique
EP2696876A4 (fr) Composition ophtalmique aqueuse
WO2014155389A3 (fr) Procédé de préparation de ticagrelor

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 13800769

Country of ref document: EP

Kind code of ref document: A2